Example: barber
Xeljanz, INN-tofacitinib citrate - Europa
hPBMCs Human peripheral blood mononuclear cells . hWB Human whole blood . HU03 Human erythro-leukemia cell line . IC50 50% inhibition concentration . ICH International Conference on Harmonisation . IFNα Interferon alpha. IFNγ Interferon gamma. Ig Immunoglobulin . IHC Immunohistochemistry . IL Interleukin . IV Intravenous . JAK Janus kinase ...
Tags:
Information
Domain:
Source:
Link to this page:
Documents from same domain
Q12 Step 2b Technical and regulatory …
www.ema.europa.euICH guideline Q12 on technical and regulatory considerations for pharmaceutical product lifecycle management EMA/CHMP/ICH/804273/2017 Page 3/36
Guideline on good pharmacovigilance practices …
www.ema.europa.eu9 December 2013 . EMA/816292/2011 Rev 1* Guideline on good pharmacovigilance practices (GVP) Module VII – Periodic safety update report (Rev 1)
Guideline on good pharmacovigilance practices (GVP)
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module IX (Rev 1) EMA/827661/2011 Rev 1 Page 2/25
Guideline on good pharmacovigilance practices …
www.ema.europa.euGuideline on good pharmacovigilance practices (GVP) – Module VIII (Rev 3) EMA/813938/2011 Rev 3 Page 2/28
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/70 Document History First Codification History Date New Codification
Guideline for good clinical practice E6(R2)
www.ema.europa.euGuideline for good clinical practice E6(R2) EMA/CHMP/ICH/135/1995 Page 2/75 10 Document History 11 First Codification History Date New Codification November
Guideline on good pharmacovigilance practices …
www.ema.europa.euharmful physical or psychological effects [DIR 2001/83/EC Art 1(1 6)]. 74 Adverse event (AE); synonym: Adverse experience 75 Any untoward medical occurrence in a patient or clinical- trial subject administered a medicinal product
European Medicines Agency
www.ema.europa.eu© EMEA 2006 2 SPECIFICATIONS: TEST PROCEDURES AND ACCEPTANCE CRITERIA FOR BIOTECHNOLOGICAL/BIOLOGICAL PRODUCTS ICH Harmonised Tripartite Guideline
products1/traditional herbal medicinal products
www.ema.europa.euThere is no expectation that existing herbal medicinal products on the market will be affected by this guideline, with the exception of traditional herbal medicinal products for human use that were already
Q7 Q&A - good manufacturing practice for active ...
www.ema.europa.euICH guideline Q7 on good manufacturing practice for active pharmaceutical ingredients – questions and answers EMA/CHMP/ICH/468930/2015 Page 2/37
Related documents
Shingrix, INN-Herpes zoster vaccine (recombinant, adjuvanted)
www.ema.europa.euPBMC Peripheral Blood Mononuclear Cell . PCR Polymerase Chain Reaction . Ph. Eur. European Pharmacopoeia . PHN Post-herpetic Neuralgia . PIP Paediatric Investigation Plan . PM In Process Monitoring . PP Process Parameters . PPQ Process Performance Qualification . PRNT Plaque Reduction Neutralization Test ...
T Cell Activation, In Vitro - Thermo Fisher Scientific
tools.thermofisher.comProtocol B: Stimulation of human peripheral blood mononuclear cells Materials 1X sterile PBS Anti-human CD3: o Clone OKT3 (Functional Grade Cat. No. 16-0037) or Clone HIT3a (Functional Grade Cat. No. 16-0039) Anti-human CD28: o Clone CD28.2 (Functional Grade Cat. No. 16-0289) Complete RPMI-1640 Sterile PBMC
話題の感染症 慢性活動性EBウイルス ... - Eiken
www.eiken.co.jp（peripheral blood mononuclear cells ; PBMC）で EBウイルス量が高値をとり、診断基準にもあるよ うに102.5 コピー/μg DNA以上のEBウイルスゲノ ムが検出されることが多い14）。血漿中のEB ウイル スDNAは、まれに感度以下であることもあるが、